IN8bio Inc [INAB] stock prices are down -3.48% to $1.11 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INAB shares have gain 0.91% over the last week, with a monthly amount drifted -11.20%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
IN8bio Inc [NASDAQ: INAB] stock has seen the most recent analyst activity on March 18, 2024, when Laidlaw initiated its Buy rating and assigned the stock a price target of $7.50. Previously, H.C. Wainwright started tracking the stock with Buy rating on August 30, 2022, and set its price target to $14.
The stock price of IN8bio Inc [INAB] has been fluctuating between $0.65 and $3.95 over the past year. IN8bio Inc [NASDAQ: INAB] shares were valued at $1.11 at the most recent close of the market.
Analyzing the INAB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.87, Equity is -1.45 and Total Capital is -1.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9709 points at the first support level, and at 0.8319 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1945, and for the 2nd resistance point, it is at 1.2791.
Ratios To Look Out For
It’s worth pointing out that IN8bio Inc [NASDAQ:INAB]’s Current Ratio is 4.57. Further, the Quick Ratio stands at 4.57, while the Cash Ratio is 3.95.
Transactions by insiders
Recent insider trading involved Graff Jeremy R., Director, that happened on Sep 13 ’23 when 2500.0 shares were purchased. Chief Financial Officer, McCall Patrick completed a deal on Aug 25 ’23 to buy 1000.0 shares. Meanwhile, President and CEO Ho William Tai-Wei bought 23800.0 shares on Aug 24 ’23.
